Rheumnow.com
Dr. Jack Cush reviews the news and journal reports from RheumNow.com, including info on scleroderma, dermatomyositis and malignancy, rheumatologist and APP salaries concerns.
rheumnow.com/video/apps-n...
Dr. Jack Cush reviews the news and journal reports from RheumNow.com, including info on scleroderma, dermatomyositis and malignancy, rheumatologist and APP salaries concerns.
rheumnow.com/video/apps-n...
Philip Mease, MD, and Cayla Alexander, DNP, ARNP, in Seattle, discuss a lupus patient's CAR-T cell therapy case for RheumNow's "Mission: APP Partners in Care" December campaign.
buff.ly/JEiker9
Philip Mease, MD, and Cayla Alexander, DNP, ARNP, in Seattle, discuss a lupus patient's CAR-T cell therapy case for RheumNow's "Mission: APP Partners in Care" December campaign.
buff.ly/JEiker9
Medscape recently reviewed off-label use of LDN in FM and found it is deemed effective by some clinicians and patients, but 1) there is no FDA indication for LDN use in FM and 2) the data supporting its use is limited.
buff.ly/FF34Uzy
Medscape recently reviewed off-label use of LDN in FM and found it is deemed effective by some clinicians and patients, but 1) there is no FDA indication for LDN use in FM and 2) the data supporting its use is limited.
buff.ly/FF34Uzy
56-yoF w/ BL hand contractures, 15 mos BL hand pain/swelling/stiffness. No or partial relief w/ ibuprofen, 30 mg prednisone, MTX 10-20 mg/wk. All labs were normal. Whats the Dx? jamanetwork.com/journals/jam...
56-yoF w/ BL hand contractures, 15 mos BL hand pain/swelling/stiffness. No or partial relief w/ ibuprofen, 30 mg prednisone, MTX 10-20 mg/wk. All labs were normal. Whats the Dx? jamanetwork.com/journals/jam...
The "One Big Beautiful Bill" (OBBB) changes healthcare education funding by lowering loan limits for graduate programs--this aims to address the federal budget, reduce the DOE's role, and counter claims that unlimited loans raise tuition in the USA.
buff.ly/CQ9bJom
The "One Big Beautiful Bill" (OBBB) changes healthcare education funding by lowering loan limits for graduate programs--this aims to address the federal budget, reduce the DOE's role, and counter claims that unlimited loans raise tuition in the USA.
buff.ly/CQ9bJom
NHS knee replacement surgeries are often cancelled at short notice each year for preventable reasons, leading to millions in costs and longer waiting times for patients in severe pain, according to a study released on December 1st.
buff.ly/5bxJxW1
NHS knee replacement surgeries are often cancelled at short notice each year for preventable reasons, leading to millions in costs and longer waiting times for patients in severe pain, according to a study released on December 1st.
buff.ly/5bxJxW1
Major interstate “compacts” allow for cross state licensing for physicians. However, compacts for Advanced Practice Registered Nurse (APRN) are fewer and currently on hold - thereby limiting healthcare manpower and patient care.
rheumnow.com/news/legisla...
Major interstate “compacts” allow for cross state licensing for physicians. However, compacts for Advanced Practice Registered Nurse (APRN) are fewer and currently on hold - thereby limiting healthcare manpower and patient care.
rheumnow.com/news/legisla...
Watch our kickoff webinar for this month's Mission: APP — Partners in Care campaign. Our panel of rheumatologists and experienced advanced practice providers share insights into hiring, onboarding, training, compensation, and more.
rheumnow.com/video/hiring...
Watch our kickoff webinar for this month's Mission: APP — Partners in Care campaign. Our panel of rheumatologists and experienced advanced practice providers share insights into hiring, onboarding, training, compensation, and more.
rheumnow.com/video/hiring...
Lindsay Tom, PA-C and Phong Nguyen, MD, Reston, VA discuss today's case called "Flare or Beware", involving a patient who has psoriatic arthritis mutilans, presented as part of RheumNow's "Mission: APP Partners in Care" campaign.
buff.ly/S9g01Pu
Lindsay Tom, PA-C and Phong Nguyen, MD, Reston, VA discuss today's case called "Flare or Beware", involving a patient who has psoriatic arthritis mutilans, presented as part of RheumNow's "Mission: APP Partners in Care" campaign.
buff.ly/S9g01Pu
Where the data meets the dialogue.
Join leading rheumatologists, researchers, and innovators at RheumNow Live 2026 — the meeting redefining rheumatology education.
🕓 Early Bird registration is open until 12/1.
Save now ➡️https://rheumnow.live
Where the data meets the dialogue.
Join leading rheumatologists, researchers, and innovators at RheumNow Live 2026 — the meeting redefining rheumatology education.
🕓 Early Bird registration is open until 12/1.
Save now ➡️https://rheumnow.live
Complex-to-manage PsA (C2M-PsA)
Treatment-refractory PsA (TR-PsA)
buff.ly/0j5A6qq
Complex-to-manage PsA (C2M-PsA)
Treatment-refractory PsA (TR-PsA)
buff.ly/0j5A6qq
Swedish national study found that among a cohort of systemic sclerosis (SSc) patients a two-fold increase risk of hematological malignancies was seen.
rheumnow.com/news/hematol...
Swedish national study found that among a cohort of systemic sclerosis (SSc) patients a two-fold increase risk of hematological malignancies was seen.
rheumnow.com/news/hematol...
Long-term APP retention is vital in rheumatology due to rising patient numbers and the need for prompt care. Integrating APPs improves practice efficiency, patient access, and clinician workload balance.
buff.ly/CDUIKQ3
Long-term APP retention is vital in rheumatology due to rising patient numbers and the need for prompt care. Integrating APPs improves practice efficiency, patient access, and clinician workload balance.
buff.ly/CDUIKQ3
Dr. Jack Cush reviews the news and reports from this past week on RheumNow, including reports on FDA resurrections, FM seasonal worsening, and do you fight switch or swap biologics in PsA TNFi nonresponders?
rheumnow.com/news/turkey-...
Dr. Jack Cush reviews the news and reports from this past week on RheumNow, including reports on FDA resurrections, FM seasonal worsening, and do you fight switch or swap biologics in PsA TNFi nonresponders?
rheumnow.com/news/turkey-...
- Rheum among lowest paid (~$284k)
- 2024 salaries rose 2%
- 53% say theyre underpaid
- 41% supplement their income
- 6/10 recv incentive bonuses resources.healthgrades.com/pro/6-surpri...
- Rheum among lowest paid (~$284k)
- 2024 salaries rose 2%
- 53% say theyre underpaid
- 41% supplement their income
- 6/10 recv incentive bonuses resources.healthgrades.com/pro/6-surpri...